MXRA5 promotes extracellular matrix remodeling and predicts poor immunotherapy response in Lung Adenocarcinoma
This study identifies MXRA5 as a hypoxia-induced driver of extracellular matrix remodeling and immunosuppression in lung adenocarcinoma via the PI3K-AKT pathway, linking its overexpression to poor prognosis and resistance to immunotherapy.